Literature DB >> 10362133

Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening.

A Kricker1, K Farac, D Smith, A Sweeny, M McCredie, B K Armstrong.   

Abstract

To examine the use of mammographic screening in women in New South Wales (NSW), we measured uptake of initial mammograms and estimated the proportions of breast cancers that were screen detected. To see if mammographic screening has been associated with reductions in advanced breast cancers and mortality from breast cancer, we analyzed trends in age-specific and age-standardized breast cancer incidence and mortality from 1972 to 1995 and tumor size in 1986, 1989, 1992 and April to September 1995. Between 1984 and the end of 1995, an estimated 72% of NSW women in their 50s and 67% in their 60s had had at least 1 mammogram and, in 1995, an estimated 39% of invasive breast cancers in women in these age groups were detected by mammography. Before 1989, breast cancer incidence increased only slightly (+1.3% annually) but then, from 1990 to 1995, increased more rapidly (+3.1% annually). Between 1986 and 1995, rates of small cancers (< 1 cm) increased steeply by 2.7 times in women 40-49 years of age and 5.6 times in women 50-69 years of age. The incidence of large breast cancers (3+ cm), after little apparent change to 1992, fell by 17% in women 40-49 years of age and 20% in those 50-69 years of age to 1995. Breast cancer mortality increased slightly between 1972 and 1989 (+0.5% annually) but then fell (-2.3% annually) from 1990 to 1995. We concluded that breast cancer rates had been influenced in expected directions by the introduction of mammographic screening in women resident in NSW. We expect that recent falls in incidence of larger breast cancers and breast cancer mortality will become steeper as screening coverage increases in the second half of the 1990s.

Entities:  

Mesh:

Year:  1999        PMID: 10362133     DOI: 10.1002/(sici)1097-0215(19990611)81:6<877::aid-ijc7>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 2.  Advanced breast cancer incidence following population-based mammographic screening.

Authors:  P Autier; M Boniol; R Middleton; J F Doré; C Héry; T Zheng; A Gavin
Journal:  Ann Oncol       Date:  2011-01-20       Impact factor: 32.976

Review 3.  The changing global patterns of female breast cancer incidence and mortality.

Authors:  Freddie Bray; Peter McCarron; D Maxwell Parkin
Journal:  Breast Cancer Res       Date:  2004-08-26       Impact factor: 6.466

4.  Breast conservation, mastectomy and axillary surgery in New South Wales women in 1992 and 1995.

Authors:  A Kricker; J Haskill; B K Armstrong
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

5.  Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients.

Authors:  J Anttinen; H Kautiainen; T Kuopio
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 6.  The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Authors:  M J M Broeders; P Allgood; S W Duffy; S Hofvind; I D Nagtegaal; E Paci; S M Moss; L Bucchi
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

7.  Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis.

Authors:  Laurie A Lindamer; Emily Wear; Georgia Robins Sadler
Journal:  BMC Psychiatry       Date:  2006-10-30       Impact factor: 3.630

8.  Decreased rates of advanced breast cancer due to mammography screening in The Netherlands.

Authors:  J Fracheboud; S J Otto; J A A M van Dijck; M J M Broeders; A L M Verbeek; H J de Koning
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.